[1] 徐发林, 张彦华, 段佳佳, 等.不同分度早产儿支气管肺发育不良临床高危因素[J].中华实用儿科临床杂志, 2013, 28(14): 1073-1076. [2] 常立文.新生儿支气管肺发育不良诊治进展[J].临床儿科杂志, 2007, 25(3):161-165. [3] 王庆欣, 李增棋.Clara 细胞分泌蛋白在肺损伤中的研究进展[J].中国体外循环杂志2011, 9(1):57-60. [4] 罗凤鸣, 王曾礼, 刘小菁, 等.Clara 细胞分泌蛋白在实验性气道炎症中的表达[J].华西医科大学学报, 2002, 33(4):511-514. [5] 陈翠娥, 狄天伟, 朱融和, 等.Clara 细胞分泌蛋白在新生儿肺部疾病中的研究进展[J].中国新生儿科杂志, 2016, 11(5):391-394. [6] 邵肖梅, 叶鸿瑁, 丘小汕.实用新生儿学[M].5版.北京:人民卫生出版社, 2019:596-602. [7] Schrama AJ, Bernard A, Poorthuis BJ, et al.Cord blood Clara cell protein CC16 predicts the development of bronchopulmonary dysplasia[J].Eur J Pediatr, 2008, 167(10): 1305-1312. [8] Ramsay PL, DeMayo FJ, Hegemier SE, et al.Clara cell secretory protein oxidation and expression in premature infants who develop bronchopulmonary dysplasia[J].Am J Respir Crit Care Med, 2001, 164(14):155-161. [9] 刘改英, 林广, 刘颖, 等.急性肺损伤/急性呼吸窘迫综合症新生儿血清Clara细胞分泌蛋白、肺表面活性蛋白A变化的意义[J].中华实用儿科临床杂志, 2013, 28(14):1090-1091. [10] Zhang H, Fang J, Su H, et a1.Risk factors for bronchopulmonary dysplasia in neonates born at≤1500 g (1999-2009) [J].Pediatr Int, 2011, 53(6): 915-920. [11] 早产儿支气管肺发育不良调查协作组.早产儿支气管肺发育不良发生率及高危因素的多中心回顾调查分析[J].中华儿科杂志, 2011, 49(9): 655-662. [12] Maskam S, Sen N, Raj JP, et a1.Correlation between lung injury score and selllm albumin levels in patients at risk for developing acute lung injury[J].Nutrition, 2000, 16(2):91-94. [13] Levine CR, Gewolb IH, Allen K, et a1.The safety pharmacokinetics and antiinflammatory effects of intratracheal recombinant human Clara cell protein in premature infants with respiratory distress syndrome[J].Pediatr Res, 2005, 58(9):15-21. [14] Hermans C, Petrek M, Kolek V, et a1.Serum Clara cell protein (CC16) a marker of the integrity of the airblood barrier in sarcoidosis[J].Eur Respir J, 2001, 18(16):507-514. |